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Abstract
Mesenchymal stromal/stem cells (MSCs) are increasingly employed for tissue regeneration,
largely mediated through paracrine actions. Currently, extracellular vesicles (EVs) released
by MSCs are major mediators of these paracrine effects. We evaluated whether rat-bone-
marrow-MSC-derived EVs (rBMSCs-EVs) can ameliorate tendon injury in an in vivo rat
model. Pro-collagen1A2 and MMP14 protein are expressed in rBMSC-EVs, and are impor-
tant factors for extracellular-matrix tendon-remodeling. In addition, we found pro-col-
lagen1A2 in rBMSC-EV surface-membranes by dot blot. In vitro on cells isolated from
Achilles tendons, utilized as rBMSC -EVs recipient cells, EVs at both low and high doses
induce migration of tenocytes; at higher concentration, they induce proliferation and
increase expression of Collagen type I in tenocytes. Pretreatment with trypsin abrogate the
effect of EVs on cell proliferation and migration, and the expression of collagen I. When
either low- or high-dose rBMSCs-EVs were injected into a rat-Achilles tendon injury-model
(immediately after damage), at 30 days, rBMSC-EVs were found to have accelerated the
remodeling stage of tendon repair in a dose-dependent manner. At histology and histo-
morphology evaluation, high doses of rBMSCs-EVs produced better restoration of tendon
architecture, with optimal tendon-fiber alignment and lower vascularity. Higher EV-concen-
trations demonstrated greater expression of collagen type I and lower expression of
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collagen type III. BMSC-EVs hold promise as a novel cell-free modality for the management
of tendon injuries.
Introduction
The incidence of tendon injuries has markedly increased over the past few decades. To date,
no viable therapeutic options provide fully successful, long-term solutions; hence, reliable,
effective, safe, innovative therapies are required. Recently, cell therapy based approaches have
been used to accelerate tendon regeneration and repair.
Tendon function is determined by the biochemical composition and macromolecular
structural organization of its extracellular matrix (ECM), which mostly consists of type I colla-
gen with smaller amounts of type III collagen[1] and other components. MMP14 (matrix
metalloproteinases 14) is necessary for tendon growth and remodeling during healing[1].
Adult, bone marrow-derived mesenchymal stromal/stem cells (BMSCs), are multipotent
stem cells which have been widely studied to treat tissue defects, and are generally considered to
be a promising alternative to the current therapeutic approach to tendon injuries[2], although
contrasting results have also been obtained. Ectopic ossification, calcification and the higher
risk of adhesions formation[3,4], as well as the inherent difficulties in quality control before
administration[3,4], are among potential problems when using BMSCs for tendon healing.
Recent investigations suggest that the therapeutic efficacy of MSCs depends on paracrine
mechanisms and, more recently, their therapeutic potential has been attributed to the secretion
of extracellular vesicles (EVs), which are membrane-enclosed lipid vesicles released by cells as
mediators of intercellular communication. Ranging in size from *50 nm to> 1μm, EVs carry
functional proteins, DNA, mRNA, ncRNA and lipids[5, 6].
Cell-free delivery of bioactive cargos by EV induces the same beneficial responses as stem-
cell transplantation, offering remarkable benefits over conventional cell-therapy: for example,
EVs avoid the risk of tumorigenesis, and heterotopic ossification and calcification[3,4] and are
immunologically unresponsive agents[7, 8]. Finally EVs play a role in tendon-healing by mod-
ulating inflammatory responses [9, 10, 11].
This pilot study explores the effect of rBMSC-EVs on an Achilles tendon injury in a rat model
to evaluate whether high and low concentrations of EVs derived from rat bone marrow stromal/
stem cells without any further supplementation would improve repair of the injured tendon.
Materials and methods
Ethics
Sixteen adult male Lewis rats each weighing between 180 and 200 g were bred and maintained in
an air-conditioned animal house under specific pathogen-free conditions. All the experiments
were conducted according to the protocols of good animal experimentation under the Italian
Health Ministry approval n˚513/2016-PR and in accordance with international laws and policies
(Directive 2010/63/EU of the European Parliament and of the Council, Italian Legislative Decree
26/2014, Guide for the Care and Use of Laboratory Animals, NIH publication 85–23, 1985).
Isolation, culture and characterization of rat BMSCs
RBMS/SCs were isolated from the tibia and femur bone-marrow from three 6 to 8-week-old
male inbred Lewis rats (ENVIGO, Wyton, UK), as recently described [3]. In brief, bone mar-
row cells at second passage (P2) were used unless otherwise stated. When nearly confluent, the
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cells in the primary culture were sub-cultured and collected for the study. In addition, MSCs
were tested by flow cytometry using specific surface markers, markers following the manufactur-
er’s instructions, namely mouse monoclonal anti-CD45/FITC, mouse monoclonal anti-CD34/
FITC, mouse monoclonal anti-CD90/APC, mouse monoclonal anti-CD44, (all purchased by BD
Pharmigen, BD Biosciences, CA, USA) and rabbit monoclonal anti-CD29 (Abcam, Cambridge,
UK) counjugated with a goat anti-rabbit IgG fluorescein conjugated secondary antibody (Merck
Millipore, Darmstadt, Germany), being negative for CD45 and CD34 and positive for CD44,
CD29 and CD90[12,13]. FITC and APC-conjugated nonspecific IgG was used as isotype con-
trols (Biolegend, San Diego, CA, USA). Debris particles were excluded from the analysis by gat-
ing on forward and side scatter (FSC and SSC) morphological parameters. At least 10,000 viable
and non-debris events in the morphological gate were recorded for each sample. Cells were
acquired on a CytoFLEX flow Cytometer (Beckman Coulter, CA, U.S.). The analysis was per-
formed using the CytExpert Software (Beckman Coulter). The stem-cell characteristics of bone-
MSCs were routinely confirmed by their trilineage differentiation abilities (adipocytes, osteo-
blasts, and chondrocytes)[3]. Adipocytes were visualized by Oil Red-O staining, osteoblasts evi-
denced by Alizarin red, and chondrocytes were visualized with Alcian Blue. Isolated rBMSCs
(P0) were cryopreserved according to standard procedures in liquid nitrogen in 90% fetal bovine
serum +10% DMSO and stored in liquid nitrogen in vials until transplantation (Fig 1).
EV isolation
The protocols used to separate EVs were in accordance with the most recent guidelines
(MISEV 2018) [14]. FBS and bovine serum albumin (BSA) solution (Life Technologies) used
for EV production were depleted from endogenous EVs prior to use by ultracentrifugation at
120,000 g for 5 hours, using an Ultracentrifuge Optima L-100K Ultracentrifuge (Beckmann
Coulter). After centrifugation, the FBS and BSA supernatants were filtered with a 0.22 μm filter
(ThermoFisher Scientific, Inc.,Rochester, NY, USA) and stored in aliquots at -80˚C.
Fig 1. Experimental design. Isolation of rBMSC; EV enrichment by differential ultracentrifugation; Rat Tendon injury model-surgical procedure;
Treatment locally micro-injected.
https://doi.org/10.1371/journal.pone.0229914.g001
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rBMSC 80%-confluent cell plates (1–2 ×106 cells/mL) were washed 2 times with PBS without
calcium and magnesium, then incubated for 24 hours in DMEM/F12 (1:1) (Life Technologies,
Carlsbad, CA, USA) supplemented with 1% EV-free FBS and 0.25% EV-free BSA at 37˚C and 5%
CO2. Cell viability was assessed using Trypan blue exclusion methods. Presence of apoptotic cells
was checked by flow-cytometric assay for annexin V expression (data not shown). EVs were pre-
pared from the cell-culture media using differential centrifugation steps as previously described
with some modification[15]. All preparation and centrifugation steps were performed at 4˚C.
Briefly, collected cell-media were subjected to a first centrifugation at 300×g for 10 min to remove
non-attached cells, followed by a second centrifugation at 2,000×g for 30 min to remove apoptotic
bodies, and finally a third centrifugation at 16,000×g for 20 min to remove residual ABs and cell
organelles. EVs were then pelleted from the purified supernatant by centrifugation at 120,000×g
for 70 min in 38 mL polycarbonate tubes (Beckman #355631). This EV-enriched pellet was resus-
pended in PBS, and the centrifugation was repeated again as above. The final EV pellets was thor-
oughly drained, rapidly frozen in liquid nitrogen and stored at -80˚C until their use.
Atomic Force Microscopy (AFM) imaging
For AFM, EVs were diluted 1:10 in MilliQ water and 5 μL of preparation were spotted on to
freshly-cleaved mica substrates (Agar Scientific, Stansted, Essex CM24 8GF United Kingdom).
Each substrate was dried at 30˚C for 10 minutes and analyzed with a NaioAFM (NanoSurf),
equipped with Multi GD-G probes (BudgetSensors). Measurements were performed in
dynamic mode, and scanning parameters were set according to the probe manufacturer. AFM
images were processed using WSxM 5.0 (http://www.wsxmsolutions.com). EV size distribu-
tion was performed on ImageJ, analyzing 10 different AFM pictures. A total of 550 particles
were measured. Only particles with a diameter of at least 30 nm were analyzed; particle round-
ness threshold was fixed to 0.800, in order to eliminate possible artifacts deriving from non-
EV objects. EV weighted mean, median and mode diameters were calculated using GraphPad
Prism 6, which was also used to plot EV size distribution data[16].
Colloidal nanoplasmonic assay
EV preparations were checked for purity and titrated by adapting the colorimetric nanoplas-
monic assay we previously developed [17, 18]. The assay synergistically exploits nanoplasmo-
nics of gold nanoparticles (AuNPs), AuNP-protein corona and AuNP membrane collective
interactions. Briefly, citrate capped spherical AuNPs adsorb and cluster at the EV membrane
in pure formulations. Instead, if the formulation contains exogenous protein contaminants,
AuNPs are preferentially coated by those contaminants, forming a AuNP-contaminant corona
which keeps AuNPs dispersed and prevents them from clustering to the EV membrane. Clus-
tering drives a red shift of the AuNPs localized surface plasmon resonance (LSPR) absorption
peak, which in turn is directly related to the purity grade of the formulation. Isolated EV sam-
ples were resuspended in sterile milliQ H2O (Q GRAD2 Millipore) and mixed with a final
concentration of 3nM, 15 nm AuNPs. The blue shift of the different AuNP-EV solutions was
quantified by collecting the spectra with a microplate UV–vis reader (EnSight Multimode
Reader, Perkin- Elmer), acquired with 1 nm step size in a wavelength window ranging from
400 nm to 900 nm. The AuNPs aggregation index (AI) was defined as
AI ¼
Absorbance524 nm
Absorbance650 nm þ Absorbance900 nm
For quantification of EV number, a calibration curve was built by using Synthetic phospha-
tidylcholine (PCh) liposomes at different concentrations, prepared as previously described
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[16]. Briefly, the proper amount of POPC (1-palmitoyl–2- oleoyl-sn-glycero-3-phosphocho-
line, Avanti Lipids) was dissolved in chloroform/methanol 6:1 (v/v). A stream of nitrogen and
overnight vacuum drying were applied to obtain a lipid film by evaporating the solvent. The
film was swollen and re-suspended in warm (50˚C) 0.9% NaCl solution by vigorous vortex
mixing. To prepare liposomes with narrow distribution, the dispersion was tip-sonicated for
30 minutes.
EV biophysical characterization
EV preparation purity, morphology and size distribution were investigated through Atomic
Force Microscopy and Colloidal Nanoplasmonic assay (CONAN). The latter exploits the prop-
erties of colloidal solutions containing gold nanoparticles (AuNPs) and EVs. All relevant data
of our experiments were submitted to the EV-TRACK knowledgebase (EV-TRACK ID:
EV180057).
Protein preparation from cells and EVs
Proteins were isolated from rBMSCs and from EVs derived from the same rBMSCs using
M-PER Mammalian protein extraction reagent supplemented with 1% of Halt Protease,
EDTA-free phosphatase-inhibitor cocktail and 1% of EDTA solution (all from Thermo Fisher
Scientific), according to the manufacturer’s indications[6]. Protein extracts were stored at
-20˚C. The concentration of total protein preparations was quantified by BCA assay (Quanti-
ProTM BCA assay kit for 0.5–30 μg/mL protein, Sigma-Aldrich, Saint Louis, MO, USA).
Western blotting
Equivalent amounts of cells and EV protein lysates were electrophoresed and transferred to
nitrocellulose membranes. Nitrocellulose membranes were then blocked in 5% non-fat milk
or 5% BSA, 10 mmol/l Tris-HCl pH 7.5, 100 mmol/l NaCl, 0.1% Tween-20, and probed with
the following primary antibodies: mouse monoclonal anti-GM130 (1:1000, BD Biosciences,
610822), mouse monoclonal anti-Annexin V (1:500, Santa Cruz Biotechnology, Dallas, U.S.,
sc-74438), mouse monoclonal anti-Annexin XI (1:500, Genetex, CA, U.S., GTX33010), mouse
monoclonal anti-TSG101 (1:500, Santa Cruz Biotechnology, sc-7964) rabbit monoclonal anti-
TERT (1:500 1000 Rockland Immunochemicals Inc., PA, U.S., 600-401-252S), mouse mono-
clonal anti-Pro-COL1A2 (D-6) (1:200, Santa Cruz Biotechnology, sc-166572), rabbit monoclo-
nal anti-Integrin beta1 (1:2000, ab179471), rabbit monoclonal anti-MMP3 (1:1000, ab52915),
and rabbit monoclonal anti-MMP14 (1:2000, ab51074) (all purchased by Abcam) and incu-
bated in the presence of specific, HRP-conjugated secondary antibodies. Immunoreactive
bands were visualized using ECL detection system (Amersham International, L.C., UK) and by
ChemiDoc XRS Imaging system (BioRad, CA, U.S.) or G:Box Chemi XT Imaging system (Syn-
gene, Cambridge, UK).
Tendon cell cultures
Rat tendon cells were isolated according to previously described protocols [19, 20, 3]. The
Achilles tendons were harvested from three male, 6 to 8-week-old, inbred Lewis rats; the ani-
mals were anesthetized and then euthanized using CO2 in specially designed chambers. Cells
were isolated from tissue sample by washing several times with Dulbecco’s phosphate-buffered
saline (PBS) without Ca2+ and Mg2+ and supplemented with 1% penicillin/streptomycin
(Invitrogen, Life Technologies,). Small pieces of fresh isolated tendon were carefully dissected
and mechanically disaggregated with the aid of fine watchmaker forceps to maximize the
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interface between tissue and medium. Finally, the tendons were immediately placed on Petri
dishes 60 mm in diameter (Greiner CELLSTAR dish, Sigma-Aldrich), containing 5 mL of α-
MEM supplemented with 20% heat-inactivated foetal calf serum (FCS), 1% L-glutamine and
1% penicillin/streptomycin (Gibco, Invitrogen, Life Technologies) at 37˚C in 5% CO2 and air
with a refresh of medium every 2–3 days. Tenocytes were harvested with StemProAccutase
(Life technologies) and centrifuged at 1,500 rpm for 5 min when cells migrated out of tendon
pieces and reached 60–80% confluence (day 19). Collected tenocytes were immediately cul-
tured to avoid phenotype drift with further in vitro passages. Cells from P2 were used for all
experiments, and the medium was changed every three days.
MTT assay for cell proliferation
Proliferation assays were performed in 96-well plates at a density of 2x103 tenocyte rat cells/
well and assayed at 48 hr. In brief, tenocytes from rats were cultured for 48 hr. in alpha-MEM
with 10% FBS. Then, the medium was replaced with fresh medium alone (used as a control) or
with EVs (2,8x1012 or 8,4x1012 /mL). At established time points, the medium was replaced
with a fresh one containing 0.5 mg/mL MTT (3–[4,5–dimethyl–thiazol–2–yl–]–2,5–diphenyl
tetrazolium bromide) growth assay (Sigma-Aldrich), and the cells were incubated for 4 hr at
37 C. After a further incubation of the samples in DMSO for 30 min at 37 C, 200 μL of each
medium were transferred into a 96-well plate, and the absorbance at 570 nm was measured
using a Multiscan GO microplate spectrophotometer (Thermo Fisher Scientific). The values
obtained in the absence of cells were considered as background and subtracted from the opti-
cal density values of the samples. Three independent experiments were performed under the
same experimental conditions. In select experiments, rBMSC-EVs were incubated with trypsin
(1 mg/mL, Sigma) for 1 hr at 37˚C and re-isolated by ultracentrifugation prior to application
as previously described [21].
Cell migration
Cell migration was performed by scratch assays. Rat tenocytes were grown to confluence in a
96-well plate and the scratch was made in the cells using a P10 pipette tip. After a PBS wash,
cultures were supplemented with or without rBMSC-EVs in reduced FBS conditions (1%
FBS). Cell migration into the empty area was monitored by bright field microscopy (NIKON,
NY, U.S.) at 0 or 24 hr. The reduction in the empty area was determined using the ImageJ soft-
ware (Version 1.49 v, RRID:SCR_003070; NIH, Bethesda, MD). The data were statistically ana-
lyzed using GraphPad Prism 5 software (GraphPad Software, Inc.). All experiments were
repeated�3 times. In select experiments, rBMSC-EVs were incubated with trypsin (1 mg/mL,
Sigma) for 1 hr at 37˚C and re-isolated by ultracentrifugation prior to application as described
above.
Immunofluorescence staining
The tendon-derived cells were seeded with 5×103 vital cells per well in 8-well chamber slides
(Thermo Fisher Scientific), in triplicates with or without rBMSC–EVs as described above.
After 0, and 7 d of culture the tendon-derived cells were fixed with pure acetone for 10 min at
−20˚C. Then, washed for a few minutes with PBS. Cells were incubated for 30 min at room
temperature with PBS containing 5% Bovine Serum Albumin (BSA) (Kedrion Group S.P.A.,
Lucca, Italy) for protein blockage. Primary antibodies for Anti-type I (1:2000) and Anti-type
III collagen molecules (1:500) (Sigma-Aldrich) and secondary antibodies fluorochrome were
diluted in PBS containing 5% BSA. Cells were incubated for 1h at 37˚C with primary antibod-
ies, and for 1 h with the appropriate secondary antibody fluorochrome at 37˚C and then
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washed a few times with PBS containing 5% BSA. Molecule staining Alexa Fluor 488 (Life
Tecnologies) was used for type I collagen and Alexa Fluor 568 (Life Tecnologies) was used for
type III collagen. Finally, a solution of 40,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich)
diluted 1000 times with PBS was added, allowed to stand at room temperature for 5 min and
washed three times with deionised water. For image analysis all digital images were captured
with NIS-Elements Imaging Software (Nikon Instruments INC.). Mean fluorescence intensity
(MFI) of the negative control was subtracted from that of each sample. The MFI (mean inten-
sity of Anti-type I-Alexa fluor 488 and Anti-type III-PE collagen molecules) fold change was
obtained by normalising MFIs (mean intensity of Anti-type I-Alexa Fluor 488 and Anti-type
III-PE collagen molecules) to the related untreated cell fluorescence. [22]. In selected experi-
ments, rBMSC-EVs were incubated with trypsin (1 mg/mL, Sigma) for 1 hr at 37˚C and re-iso-
lated by ultracentrifugation prior to application as described above.
Animal surgery and pilot study design
Sixteen 6–8 week-old male inbred Lewis rats (ENVIGO) were housed under controlled condi-
tions in the Interdepartmental Service Centre—Station for Animal Technology, University of
Rome “Tor Vergata” (Italy), supplied with standard diets (4RF18; Mucedola srl, Italy) and water
ad libitum. At time of surgery, general anesthesia was induced with an intramuscular injection
of tiletamine/zolazepam (50 mg/kg) (Zoletil 100) and xylazine (10 mg/kg) (Rompun Bayer).
Under general anesthesia, the right Achilles tendon was laid open by a skin incision of approxi-
mately 10 mm on the medial side of the right hind-limb of each rat. In each animal, a bilateral
Achilles tendon defect 2 mm in diameter was produced as described in our recent study[3].
The animals were divided into four groups (4rats /group). The injured tendon was filled
(immediately after skin suture) with 50 μL of Phosphate-buffered saline (PBS), which is a phys-
iological buffer solution containing: (1) PBS alone (control group: CTRL); (2) “rBMSCgroup”:
4 x106 cells; (3) “EVL group”: 2.8x10
12 EVs; (4) “EVH group”: 8.4x10
12 EVs. (Fig 1) Post-opera-
tively, antibiotics and analgesics were administered: 0.5 mL/kg baytril (Bayer AG) and 0.1 mL/
kg/day rimadyl (Veterfarma SpA). After 30 days, the animals were anesthetized and then
euthanized using CO2 in specially designed chambers. Both tendons were explanted, embed-
ded in optimal cutting temperature (O.C.T.) compound medium (Sakura Finetek USA), and
quickly frozen in liquid nitrogen-cooled isopentane for sectioning at a thickness of 12 μm on a
Leica cryostat and then stained with hematoxylin and eosin (H&E), or Picro-Sirius red solu-
tion for histological and histomorphometric analyses. (Fig 1)
Histological and histomorphometric examination
Three consecutive slides stained with H&E were evaluated through a modified semi-quantita-
tive score obtained using Soslowsky, Svensson, and Cook’s scoring systems (Table 1)[3]. These
scores take into account 4 different parameters: fiber structure, cellularity, vascularity and car-
tilage formation, rating each from 0 to 3. The overall score is the sum of the values of each
parameter and, as indicated in Table 1, the best possible score is 0; the higher the values are,
the worse the pathology.
Histological images were analyzed using an Aperio ScanScope digital image analysis system.
The entire tendon surface was analyzed, and histological scores were assigned by two blinded
independent histologists.
Three other consecutive slides for each sample were stained with Picro-Sirius red solution.
Using an optical microscope (BX51, Olympus Italia Srl) at 8X magnification, collagen type I
and type III percentages were calculated by automated measurement of the red-orange fiber
area (collagen type I) and pale green fiber area (collagen type III) from these slides[3].
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Statistical analyses
In vitro data are typical results from a minimum of three replicated independent experiments,
and are expressed as mean ± SD. Comparison of individual treatment was made using Stu-
dent’s t test. A one-way ANOVA test was used for comparison of three or more groups, and
was followed by Tukey’s post hoc test. Differences were considered significant when � p< 0.05,
� ��p< 0.01, ��� p< 0.001, ���� p< 0.00001.
According to the “One-between, one within factor, repeated measures ANOVA” formula
based on the ‘resource equation’ approach[23], the minimum and maximum numbers of rats
required in our study were 2.25 (rounded up to 3) and 3.5 (rounded up to 4) rats/group-treat-
ment, respectively.
Ordered probity regression models and linear regression models with the treatment-group
as covariate, followed by Bonferroni-adjusted post hoc test, were used to compare the effect of
treatments on the histological scores and the collagen ratios, respectively. Cluster robust stan-
dard errors were computed in order to take the correlation among the two histologists per rats
into account. Statistical analysis was performed using the STATA v.14.2 software.
Statistical analyses were performed using the GraphPad Prism Software 5.0. Data are
expressed as mean values ± standard deviation (SD). Statistical significance was set at p� 0.05.
Results and discussion
We separated EVs from rBMSC-conditioned media using a previously published, validated
protocol[3], and characterized them according to the most recent guidelines of the Interna-
tional Society for Extracellular Vesicles (MISEV 2018)[14] (Fig 2A, 2B, 2C, 2D and 2E).
Biophysical analysis data indicate that enriched EV populations were obtained from
rBMSCs. The purity, size distribution and number of separated EVs were revealed by Atomic
Force Microscopy (AFM) and Colloidal nanoplasmonic (CONAN) assay (Fig 2F, 2G and 2H).
Western blot analysis, using antibodies against surface and internal makers, excluded contami-
nation by other membrane fragments (GM-130), confirmed EV-specific marker-expression
(Annexin XI, Annexin V and TSG-101), TERT-expression (in accordance with a recently-dis-
covered biomarker on amniocyte-derived EVs[24]) and characteristic CD29 protein-expres-
sion of the parental MSCs (Fig 2I).
rBMSCs-EV express Pro-collagen1A2 and MMP14
As tendon ECM is largely composed of Collagen Type I, we investigated Collagen Type I pre-
cursor-expression in EVs by western blot. We identified the presence of Pro-collagen1A2 in
EVs, and demonstrated, by dot blot, that Pro-collagen1A2 predominantly labels the EV-mem-
brane surface (Fig 3A and 3B).
Table 1. Semiquantitative histomorphometric scoring system as modified by Svensson, Soslowsky, and Cook.
Parameter Score (points) 0 (Health
Tendon)
Score (points) 1 Score (points) 2 Score (points) 3
Fiber Structure, Svensson
and Soslowsky Modified
Normal parallel collagen fibers Mild changes (collagen fibers
<25% disorganized, increased
waviness)









nuclei with no cytoplasm at
light microscopy
Nucleus becomes more ovoid
without conspicuous cytoplasm
Increased roundness and size of the
nucleus and little cytoplasm




Few vessels, parallel to collagen
fiber
Slight increase of vessels Moderate increase of vessels Markedly increased of vessels
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Fig 2. rBMSC characterization. An example of rBMSC phenotype and functional analysis. (A) Flow cytometry
analysis of MSCs was performed with FITC-conjugated antibodies (red histograms) and PE-conjugated antibodies
(green histogram) to detect cell surface markers. The expression of isotype controls is shown in the black histograms.
Flow cytometry analysis revealed typical CD44, CD29 and CD90 mesenchymal surface-marker expression, without
CD45 and CD34 hematopoietic surface markers, and confirmed that only mesenchymal cells had been isolated
(CD45-CD34-CD29+CD44+CD90+ cell population). (B, C, D, E) In vitro differentiation of Mesenchymal Cells. The
cells were shown to be multipotent stem-cells by differentiation capacity along osteogenic, chondrogenic and
adipogenic lineages.(B): Cells were incubated in lineage-specific induction media and then analyzed by histochemical
and cytological staining for (C) Adipocytes (Oil Red-O staining), (D) Chondrocytes (Alcian blue staining) and (E)
Osteoblasts (Alizarin Red staining). Characterization of rat BMSC derived extracellular vesicles. (F) AFM topography
image of the EV preparations. Scale bars are 1 μm. (G) CONAN assay. (H) Size distribution and diameter of EV
samples. (I) Representative western blots showing the expression of: GM130, ANX XI, TSG 101, ANX V, TERT and
CD29 (Integrin beta1) in rBMSC and rBMSC-derived EVs. Uncropped gel from different gels. Experiments were
performed 3 times with similar results.
https://doi.org/10.1371/journal.pone.0229914.g002
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WB analysis confirms the presence of MMP14 (also known as membrane type 1 MMP, or
MT1-MMP) in rBMSC-EVs (Fig 3C) in accordance with other studies. Gulotta et al. have
hypothesized that MMP-14 in tenocytes may induce regeneration[1]. Furthermore, MMP14
Fig 3. (A) Representative Western blots showing Pro-collagen1A2 expression in rBMSC and rBMSC-derived EVs.
Panel A, representative Western blotting of Pro-COL1A2. Uncropped gel. (B) Demonstration that Pro-COL1A2 labels
the surface membrane of EVs. EVs were dot blotted on nitrocellulose membrane in a dose range followed by
immunoprobing with anti-Pro-COL1A2 (1:200) or anti-Annexin V (1:500) (Santa Cruz Biotechnology) or anti-Ago2
(1:1000) (OriGene Technologies), respectively, and horseradish peroxidase (HRP)-conjugated secondary antibodies in
the presence or absence of detergent [0.1% (v/v) Tween20] for chemiluminescence detection. After immunoreaction
with the specific antibody, dot blot showed the protein is mainly associated to EV surface rather than in EV lumen;
indeed, Pro-collagen1A2 was detected even in absence of Tween-20, which permeabilizes EV membranes and allows
the detection of EV lumen-associated proteins. AGO2 and annexin V are here used as controls: the first as an indicator
of EV integrity the latter as representative of EV membrane-bound protein. (C) Matrix metalloproteinase 14 and
Matrix metalloproteinase 3 detection by representative Western blotting. Uncropped gel. Matrix metalloproteinase 14
was highly concentrated in EVs secreted by rat bone marrow stem/stromal cells. Matrix metalloproteinase 3 was
present only in rBMSCs.
https://doi.org/10.1371/journal.pone.0229914.g003
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in EVs are crucial in increasing cell migration and activating pro-MMP2, as well as in the deg-
radation of ECM-proteins [25]. We were further interested to analyze MMP3, which seems to
be crucial in connective-tissue remodeling and has been found in adipocyte-derived EVs [26].
Furthermore, Wang et al. have been shown that EV derived from tendon stem cells, injected
on rat tendon injury model significantly decreased MMP3 expression and increased the
expression of Collagen type I promoting tendon healing [27, 25]. However, our WB analysis
showed the complete absence of MMP3 in rBMSCs-EVs, despite its confirmed presence in the
originating rBMSCs (Fig 3C).
rBMSC–EVs induce proliferation, migration and expression of collagen
type I of rat tendon-derived cells
First, interaction of rBMC -EVs on the recipient tendon-derived rat cells was assessed. We
analyzed the metabolic activity of tenocytes when exposed to different concentrations of
rBMC -EVs (2,8x1012 or 8,4x1012 /ml) for 48 hr. The MTT results showed that rBMC -EV
treatment with the higher concentration (rBMC-EVH (High)) exerted a significant effect on
tenocyte proliferation, metabolic activity being increased by up to 34%. (Fig 4A). Scratch
wound healing assays showed that both the lowest and highest rBMC–EVs induced a signifi-
cant pro-migration effect in the tenocytes (Fig 4B). Next, we determined and measured the
type of collagen deposited by tendon-derived cells after stimulation with rBMC -EVs. Collagen
accumulation was evaluated by immunofluorescent staining of cells cultured on chamber
slides for 7 days. The expression of collagen type I in the presence of rBMC-EVs increased in a
dose-dependent manner. Furthermore, in the presence of rBMC–EVH the expression of colla-
gen type I was significantly higher compared to both untreated cells (used as a control) and
rBMC–EVL (Low) (Fig 4C). Collagen type III was not found to be present in any culture con-
ditions (data not shown). These data demonstrate that all BMSC -EVs induce proliferation
and migration of tendon-derived cells and increase their collagen type I expression. From the
data obtained, we can hypothesize that the combination of all these effects may positively regu-
late Achilles tendon repair. Higher doses of rBMSC -EVs induced proliferation and expression
of collagen type I, while both lower and higher doses of rBMSC–EVs induced migration. As it
has been previously suggested for other tissue models [21], EVs may be assumed to play an
important role at Achilles tendon injury sites in vivo and where, in all probability, an EV-con-
centration gradient effect exists. With both lower and higher concentrations of EVs, tenocytes
may be recruited at a distance, and tenocytes can increase in number at higher EV concentra-
tions and increase collagen type I fiber formation.
Recent research has already demonstrated that surface-associated proteins are key to EV-
bioactivity [21]. Thus, we verified in our model whether the bioactivity effects of EVs were
dependent on proteins bound to the EV-membrane. EV membrane–bound proteins were
digested through pre-treatment with trypsin. In agreement with Jiajia Xu et al. [21], our data
showed that pre-treatment with trypsin completely abrogated the proliferation, migration and
expression of collagen type I effect of rBMC–EVs.(S1A and S1B Fig and S1C Fig respectively).
Our results showed that rBMC—EV uptake and bioactive effects were dependent on mem-
brane-bound protein interaction with recipient tendon cells. Thus, these results can let us
speculate that less targeting of EVs can reduce their effects versus tendon repair.
rBMSC-EVs promote Achilles tendon injury repair in vivo
To investigate whether rBMSC-EVs ameliorate Achilles tendon injury repair in vivo, we evalu-
ated their effects in a rat model. Surgical core lesions of the Achilles tendon were produced in
both hind limbs of rats, and EVs were immediately injected locally in two different
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concentrations. In detail, all injured tendons were filled with 50 μL of phosphate-buffered
saline (PBS), which contained EVL (2.8x10
12) and EVH (8.4x10
12), the same concentration as
already used in in vitro experiments. As a control, we used a non-treated Achilles tendon
injury (i.e. an Achilles tendon injury in which PBS only had been injected) and an rBMSC-
treated group (Fig 1). We analyzed the effects of EVs after 30 days on semi-quantitative, histo-
morphometric results (Fig 5).
The higher concentrations of rBMSC-EVs improve tendon healing, with no detectable local
adverse reactions. The total score (Table 1) for the higher concentration (EVH) group was sig-
nificantly lower than for the rBMSC and the EVL (p = .018 and p = .017 respectively) and
lower than for the control group (p = .088) (Fig 5B). In greater detail, the sub-scores of the
EVH group were lower for fiber structure than other groups, and significantly lower than the
rBMSC group (p = .000), EVL (p = .000), and the control group (p = .000); for cellularity
scores, the sub-scores of the EVH group were lower than for the rBMSC, the low concentration
Fig 4. rBMSC-EVs promote tendon-derived cell proliferation and migration, and increase expression of collagen type I. A) Effects of
rBMC–EVs on cell proliferation in cells isolated from rat tendons. Different concentrations of rBMC–EVs (2,8x1012 or 8,4x1012 /mL) for 48 hr
determined by MTT assay. Data are reported as means ± SD. All experiments were repeated 3 times. B) tenocyte migration assessed by scratch
wound healing assay at 24 hr with or without rBMSC -EVs (2,8x1012 or 8,4x1012 /ml). Representative 100x images with percentage gap closure
are shown. C) Collagen type I, expression of tendon-derived cells in an in vitro culture isolated from four male 6 to 8-week-old inbred Lewis
rats, and stained as described in material and methods section under Immunofluorescence Staining. Representative images from 3
independent experiments. Expression of collagen type I after 7 d of culture in green fluorescence and in blue fluorescent (nucleus staining)
images showing the tendon-derived cells. Quantification of the immunohistochemistry in rBMC–EVH induced the expression of collagen type
I significantly after 7 d of in vitro culture. The mean fluorescent intensity/pixel was measured and expressed to corresponding tendon-derived
cell. Collagen type I Intensity (Total Area was quantified by anti-collagen type I) was measured by Nikon software. Data are expressed as mean
± SD for 3 independent experiments for samples run in triplicate. Scale bar (a.): 50 μm. Data shown as mean ± SD, and represent triplicate
experimental replicates. White scale bar: 20mm. Black scale bar: 100 nm. �p<0.05; ��p<0.01; ���p<0.001; ���� p< 0.00001.
https://doi.org/10.1371/journal.pone.0229914.g004
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Fig 5. (A) Histological analysis of tendon healing at 30 days from injury / start of treatment (on the left panel). The injured Achilles
tendons were then stained with H&E for each type of treatment and the quality of tendon repair was evaluated based on properties
displayed. [Arrow: (Slight Cartilage Formation)] (x500). On the right panel, longitudinal sections of the right hindlimb rat Achilles
tendons stained by Picro-sirius red staining (PSR): (magnification 4×, scale bar = 500 μm). The thicker, mature collagen fibers appear
red-orange (type I collagen); the thinner collagen fibers appear pale green (type III collagen). (B, C) Stacked histograms of the
semiquantitative histomorphometric score for treated and saline control groups. (B) Total score for healthy tendon score, including
cartilage formation, vascularity, cell appearance, and fiber structure scores (Mean, n = 8). (C) Detailed sub-scores. (D) Histograms of
Type I and Type III collagen content, expressed in percentages, for treated, and saline control groups (mean ± SD, n = 8). One-way
ANOVA test and adjusted Bonferroni (two-way) post-hoc. Intra-class correlation for histological scores was excellent for inter-observer
reliability (0.79–0.97 depending on score/sub-score). The lesions could be clearly identified on all H&E-stained slices. Histological
analysis indicated incomplete restoration of structural integrity.
https://doi.org/10.1371/journal.pone.0229914.g005
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EVL groups and the control group; for vascularity, the sub-scores of the EVH group were lower
than for the rBMSC and low concentration EVL and significantly lower than for the control
group (p = .041); the cartilage-formation sub-scores for the higher concentration EVH group
were lower than for the rBMSC, low concentration EVL and control groups (Fig 5C). Collec-
tively, in the EVH group, only the cellularity sub-score value was slightly higher than the
untreated control group, but we should underline that less cartilage formation, and better fiber
structure, were observed than in comparison with all the other treated groups (Fig 5C). In
summary, histological evaluation of the EVH group confirmed better restoration of tendon
architecture, with optimal alignment of tendon fibers and blood vessels (Fig 5A, 5B and 5C).
Analysis of the collagen ratio revealed that the EVH group had a greater effect on tendon-heal-
ing than all the other treatments. Specifically, the collagen type I value was higher than in the
rBMSC, EVL and control groups; the EVH-group collagen-type-III value was lower than in the
rBMSC, EVL and control groups (Fig 5D). However, EVL also induced a slight increase in col-
lagen-type-I expression and decrease in collagen-III expression, compared to the rBMSC and
control groups. The collagen ratios for the rBMSC group and the EVL group were lower than
the untreated saline control value (Fig 5D). It should be noted that the quantity of EVs used in
the low concentrations was obtained from the same number of BMSC cells (4 X106) as were
used in the tendon injections. In summary, in the tendons treated with a higher concentration
of EVs, analysis of the collagen ratios demonstrated higher expression of collagen type I, and
lower expression of collagen type III, than in all the other groups, including the untreated
saline control group.
The three main phases of tendon healing, featuring distinctive cellular and molecular
cascades, are: (i) inflammatory; (ii) reparative or proliferation, characterized by cellularity
and matrix production, (mostly collagen type III) and (iii) remodeling (consolidation and
maturation), replacing collagen type III with collagen type I and permitting fiber organization
[28]. Taken together, results indicate that high concentrations of EVs accelerate tendon
healing.
Collectively, the expression of pro-collagen type I and MMP14 led us to hypothesize that, in
accordance with studies describing EV-driven, matrix-remodeling in other tissue-types, this
may also occur in tendon-tissue repair[29]. Furthermore, a number of studies have shown that
MMP-14 plays a pivotal role in collagen homeostasis and remodeling, and, additionally,
MMP14 has been demonstrated to potentiate angiogenic processes[30, 31]. The precise role of
EV-MMP-14 in tendon healing and repair requires further investigation. We performed
experiments in vitro on cells isolated from Achilles tendons which were used as recipient cells
for rBMSC–EVs: our results very clearly show that EVs at both low and high doses, as used in
an in vivo model, induce proliferation and migration of tenocyte cells and increase expression
of Collagen type I. Our results are in agreement with other recent work by [21], so we may
hypothesize, as has already been suggested, that the effects of our EVs vary according to con-
centration and low and high concentrations probably have distinct roles in overall processes.
Furthermore, importantly our experiments demonstrate that EVs induce increased expression
and thus production only of Collagen type I and not of collagen type III, which makes them a
fundamental part of the repair process for optimal functional repair. Collagen type III is
already highly-expressed only in pathological tendons or during the first phase of inflamma-
tion/repair. Importantly, the pretreatment with trypsin confirms what others have already
shown, namely that lowering the vesicle uptake versus the recipient cells reduces the bioactive
effect of the vesicles, and consequently, in our model, the ability to play a role during the ten-
don repair process. Our animal model study data suggest that EV-treatment accelerates the
progression of healing in the remodeling stage of tendon repair in dose-dependent manner.
Higher concentrations of MSC-derived EVs performed better than low concentrations and
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better than MSCs alone. As already shown [9, 10, 11], three studies have already been pub-
lished on this topic, but direct comparisons with the present investigations are difficult given
the different focus. The three previous studies focused largely on inflammatory mechanisms,
and used different methodologies and different types of injury over different time periods. Fur-
thermore, variation in EV-application strategies again renders comparisons limited. Most
importantly, our study confirms the hypothesis that EVs improve tendon-healing.
In addition, what may be drawn from our study is that the analysis and identification of
optimum EV-concentrations over the three-phase tendon-healing process is of fundamental
importance and deserves further investigation. High collagen type I expression seems essential
to obtain faster tendon healing. The initial increased production of collagen type III shifts to
greater collagen type I production early in the healing process. Our data suggest that EV-treat-
ment accelerates the progression of healing in the remodeling stage of tendon repair in a dose-
dependent manner, with higher concentrations of EVs influencing the collagen ratio, increas-
ing collagen type I levels. Together with previous studies, it also becomes clear that a delivery
support should be used to concentrate treatment at the site of injury. Finally, full understand-
ing of the exact mechanisms through which EVs can influence tendon-healing can only be
obtained through extensive study into this most promising approach. A final consideration, in
our case, is that only medium-term effects have been evaluated, and further analysis is required
to establish the short- and long-term structural and functional benefits, including improved
strength and stiffness, of rBMSC-EV treatment in tendon-healing.
Our results enhance knowledge of EVs and their potential for future use as highly effective
therapeutic agents in tendon-injury treatments, while avoiding the use of cells, exogenous GFs,
or gene delivery systems.
Supporting information
S1 Fig. rBMSC-EVs pre-treated with trypsin abrogate tendon-derived cell proliferation
and migration, and increase expression of collagen type I. rBMSC -EVs were pre-treated
with trypsin, followed by re-isolation of EVs and application to tendon-derived cells. A) Effects
of rBMC–EVs on cell proliferation assessed by MTT assay at 48 hr, with different concentra-
tion of rBMC–EVs (2,8x1012 or 8,4x1012 /mL), with or without trypsinization. B) tenocyte
migration assessed by scratch wound healing assay at 24 hr with rBMSC -EVs (2,8x1012 or
8,4x1012 /ml), with or without trypsinization. C) Expression of collagen type I after 7 d of rat
tenocyte culture with rBMSC -EVs (2,8x1012 or 8,4x1012 /ml), with or without trypsinization.
The expression of collagen type I was assessed by anti-collagen I-alexa-fluor 488 staining. The
mean fluorescent intensity/pixel was measured and expressed to corresponding tendon-
derived cell. Collagen type I Intensity (Total Area was quantified by anti-collagen type I) was
measured by Nikon software. Data shown as mean ± SD, and represent triplicate experimental
replicates. �p<0.05; ���� p< 0.00001.
(TIF)
S1 Raw images. Berardi et al.
(PDF)
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